这些结果为内皮祖细胞(EPC)的募集的机制提供新的视角，同时为阻止病理性血管发生的新方法提供依据。
Thus, our results provide new insights into the mechanisms underlying EPC recruitment and the bases for novel strategies to hinder pathological angiogenesis.
内皮祖细胞为缺血性疾病以及肿瘤的治疗提供了另一新的靶点。
More and more studies proved that the endothelial progenitor cells provide a therapeutic stratagy for the ischemic diseases and the tumor.
内皮祖细胞为缺血性疾病以及肿瘤的治疗提供了另一新的靶点。
More and more studies proved that the endothelial progenitor cells provide a therapeutic stratagy for the ischemic diseases and the tumor.
应用推荐